ABEVMY 400 mg/16 ml conc 100 mg flac perf 1 pce

7680702610023 CH-70261 L01FG01 07.16.1.

Active substances:

No images available

Details

Product number
7026102
CPT
-
Packaging group
1
Unit
Durchstechflasche(n)
Composition
bevacizumabum 400 mg, trehalosum dihydricum, natrii dihydrogenophosphas dihydricus, dinatrii phosphas, polysorbatum 20, natrii hydroxidum ad pH, acidum phosphoricum ad pH, aqua ad iniectabile q.s. ad solutionem pro 16 ml corresp. natrium 17.9 mg.

Articles (1)

Abevmy 400 mg/16 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
01/03/2026
Professional SmPC
Français
01/03/2026
Professional SmPC
Italien
01/03/2026

Detailed composition

Substance Quantity Type Category
bevacizumabum
400.0 MG Substance Wirkstoff (Principe actif)
trehalosum dihydricum
- Substance HNIDK
natrii dihydrogenophosphas dihydricus
- Substance HNIDK
dinatrii phosphas
- Substance HNIDK
polysorbatum 20
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
acidum phosphoricum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
17.9 MG Substance HBESI

Reimbursement information

Public price
CHF 924.60
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/03/2026

Authorization holder

Medius AG

4132 Muttenz

Authorization information

Swissmedic authorization number
70261
Drug name
Abevmy, Konzentrat zur Herstellung einer Infusionslösung
Galenic form
KOINF
ATC Code
L01FG01
Authorization status
Z
Dispensation category
A
First authorization
03/11/2025
Authorization expiration date
02/11/2030
IT number
07.16.1.
Domain
Human medicine
Field of application
Onkologikum

Packaging details

Description (FR)
ABEVMY 400 mg/16 ml conc 100 mg flac perf 1 pce
Description (DE)
ABEVMY 400 mg/16 ml Konz Inf 400 mg Durchstf 1 Stk
Market launch
01/03/2026
Narcotic (BTM)
No

Other packaging sizes

ABEVMY 100 mg/4 ml conc inf 100 mg flac perf 1 pce
1 DUR
View
Buy us a coffee Explore the data